Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New antiepileptic medications]

J Pimentel1, F Pinto

  • 1Serviço de Neurologia, Hospital de Santa Maria, Lisboa.

Acta Medica Portuguesa
|January 1, 1995
PubMed
Summary

New antiepileptic drugs (AEs) offer advancements for refractory epilepsy patients. Further trials are crucial for optimizing treatment strategies and managing epilepsy effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Knowledge, attitudes, and behaviors questionnaire on environmental sustainability in intensive care unit (KABQES-ICU): Validity and reliability study.

Intensive & critical care nursing·2026
Same author

Septic arthritis of the temporomandibular joint managed with arthroscopy: a case report.

International journal of oral and maxillofacial surgery·2023
Same author

Diagnostic yield of muscle biopsies in pediatric population: a tertiary center experience.

Revista de neurologia·2021
Same author

The impact of COVID-19 outbreak on urolithiasis emergency department admissions, hospitalizations and clinical management in central Italy: a multicentric analysis.

Actas urologicas espanolas·2020
Same author

Aorto-left ventricular tunnel: a rare cause of heart failure in the newborn.

Images in paediatric cardiology·2019
Same author

Review: Challenges in the histopathological classification of ganglioglioma and DNT: microscopic agreement studies and a preliminary genotype-phenotype analysis.

Neuropathology and applied neurobiology·2018

Area of Science:

  • Pharmacology
  • Neurology
  • Clinical Pharmacy

Background:

  • Epilepsy affects 25% of patients refractory to current medical therapies, with limited surgical options.
  • The ideal antiepileptic drug (AED) with a known mechanism, broad efficacy, perfect pharmacokinetics, and no side effects remains elusive.
  • New AEDs are developed through molecular modifications or by targeting neurotransmitter balance (GABA/glutamate).

Purpose of the Study:

  • To review recently marketed and emerging antiepileptic drugs (AEDs).
  • To emphasize pharmacokinetic profiles, side effects, drug interactions, and clinical applications.
  • To highlight the progress in managing refractory epilepsy.

Main Methods:

  • Review of new antiepileptic drugs (AEDs) including Vigabatrin, Lamotrigine, Oxcarbazepine, Gabapentin, and Zonisamide.
  • Emphasis on pharmacokinetic properties, adverse effects, and drug interactions.
  • Analysis of clinical utility in epilepsy management.

Main Results:

  • New AEDs represent significant progress in treating refractory epilepsy patients.
  • Specific drugs reviewed show varied pharmacokinetic profiles, side effect profiles, and interaction potentials.
  • These advancements improve management options beyond existing therapies.

Conclusions:

  • The reviewed new antiepileptic drugs (AEDs) offer substantial benefits for refractory epilepsy.
  • Further well-designed comparative trials in monotherapy and polytherapy are essential.
  • Optimized drug management strategies are needed for effective epilepsy treatment.

Related Experiment Videos